Combination of a Mcl-1 inhibitor and a standard of care treatment for hematologic cancers, uses and pharmaceutical compositions thereof

• 收藏
• 分享

专利权人:

Les Laboratoires Servier;Novartis AG

发明人:

Wei, Andrew,Moujalled, Donia,Pomilio, Giovanna,Geneste, Olivier,Maragno, Ana-Leticia

申请号：

AU2018288520

公开号：

AU2018288520A1

申请日:

2018.06.21

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

A combination comprising a Mcl-1 inhibitor and a second anticancer agent, wherein the second anticancer agent is selected from anthracyclines, cytarabine and hypomethylating agents, and compositions and uses thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/